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Background: Diabetic ketoacidosis (DKA) is a potentially life-threatening acute complication of type 1 diabetes
mellitus (T1DM). Although the frequency of DKA as first manifestation of T1DM is higher in developing compared
developed countries, there is paucity of information on its characteristics in developing countries.
Methods: This retrospective study determined the frequency of ketoacidosis at diagnosis of new-onset type 1 diabetes
and described the clinical characteristics of the patients seen between 1996 and 2011 by auditing the hospital records
of all cases. The diagnosis of diabetic ketoacidosis (DKA) was based on the presence of hyperglycaemia (blood glucose
> 11 mmol/L), acidosis (serum bicarbonate < 15 mmol/L) and ketonuria (urine ketone ≥1+).
Results: At diagnosis of new-onset type 1 diabetes mellitus, three-quarter (77.1%) of the children and adolescents
presented with DKA. Comparing the frequency of DKA during the initial 8 years (1996–2003) with the later 8 years
(2004–2011), it was 81.8% vs 73.1%; p > 005. The frequency has not shown any significant declined over a 16-year
period. The frequency of re-admission in ketoacidosis was 24.3%.
Conclusion: Three-quarter of children and adolescents present with DKA as first manifestation of T1DM with no
significant decline in frequency over a 16-year period in our hospital.
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Diabetic ketoacidosis (DKA) is a potentially life-
threatening acute complication of type 1 diabetes melli-
tus (T1DM), characterized by a biochemical triad of
hyperglycaemia, ketonaemia (ketonuria) and acidaemia.1
DKA is caused by a decrease in effective circulating in-
sulin associated with elevations in counterregulatory
hormones [1,2].
The likelihood of ketoacidosis occurring at the onset
of diabetes varies considerably (between 15% and 67%)
from one country to another [3]. Studies have shown
that in parts of the world where the prevalence of
T1DM is low, symptoms of diabetes may be less familiar
to medical practitioners, as a consequence more DKA
occurs as the initial presentation of diabetes [4]. The
same is true where access to medical care is limited.* Correspondence: alpndiony@yahoo.com
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distribution, and reproduction in any mediumObservational studies from African countries suggest
that the frequency is high but the exact figures are
scarce. However, the report of a few studies from Africa
indicated that the frequency varied from 80% to 88%
[5-7]. The reason for DKA at onset of newly-diagnosed
diabetes is multifactorial [8]. The management of DKA,
in itself, imposes a significant economic burden on the
patient and his family, particularly in developing coun-
tries [9,10]. DKA is the most frequent cause of diabetes-
related death in children with the mortality rate ranging
between 6% and 24% in developing countries [11,12].
Understanding factors associated with DKA has the
potential of improving our knowledge of the disease, en-
hancing the development of patient, professional- and
population-based interventions to reduce the proportion
of children whose first presentation is DKA. The pur-
pose of the present study was to determine the fre-
quency of DKA at diagnosis of new cases of T1DM andentral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Table 1 Distribution of age and gender of patients with
diabetic ketoacidosis
Age (years) Gender
Male Female Both sexes
No (%) No (%) No (%)
Below 10 2 (13.3) 0 (0.0) 2 (5.4)
10–12 2 (13.3) 6 (27.3) 8 (21.6)
13–15 8 (53.3) 14 (63.6) 22 (59.5)
Above 15 3 (20.1) 2 (9.1) 5 (13.5)
Total 15 (100.0) 22 (100.0) 37 (100.0)
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among these patients.
Methods
In this retrospective study, the case records of all chil-
dren and adolescents with type 1 diabetes mellitus com-
plicated by diabetic ketoacidosis seen in the Department
of Child Health, University of Benin Teaching Hospital
(UBTH), between 1996 and 2011 were retrieved and
audited. Information extracted included age, sex, pre-
senting features, laboratory findings, parents educa-
tional attainment and occupation, fluid/electrolyte/
insulin management, complications, and outcome of the
patient. The socio-economic status of the patients’ par-
ents was determined using the criteria suggested by
Ogunlesi et al. [13]. This was analyzed via combining
the highest educational attainment, occupation and in-
come of the parents (based on the mean income of each
educational qualification and occupation). In this way,
the subjects were categorized into socioeconomic clas-
ses: class I (high), class II (middle) and class III (low).
The study design was approved by the relevant hospital
(UBTH) authority. The current criteria for the diagnosis
of DKA published by the International Society for
Paediatric and Adolescent Diabetes (ISPAD) is blood
glucose concentration greater than 11 mmol/L, blood
pH less than 7.3 (serum bicarbonate level < 15 mmol/L)
and ketonuria [14]. The severity of DKA is classified based
on the degree of acidosis into mild, venous pH 7.2-7.3 (bi-
carbonate 15–18 mmol/L); moderate, pH 7.1- <7.2 (bicar-
bonate 10–14 mmol/L); and severe, pH < 7.1 (bicarbonate
< 10 mmol/L) [2,14]. Outcome was measured in terms
of death or survival. Descriptive statistics such as
frequencies, means, ratios, standard deviations, confi-
dence intervals, percentages were used to describe all
the variables. The significance of differences in propor-
tion was assessed with Z-test while the differences in
means was assessed with Student t test with p-value
set at <0.05.
Consent
Informed consent was obtained from the patients/their
parents for publication of this report.
Results
Among a total of 48 patients with Type 1 diabetes melli-
tus (T1DM) who were hospitalized during the 16-year
period under review, 37(77.1%), 95% Confidence Inter-
val, CI = 76.2-78.0, presented with diabetic ketoacidosis
(DKA) at first diagnosis of diabetes. Of these 37, 15
(40.5%) were males while 22(59.5%) were females, giving
a male-to-female ratio of 1:1.5. Comparing the frequency
of DKA among newly diagnosed diabetes during the ini-
tial 8 years (1996–2003) with during the later 8 years(2004–2011), it was 81.8% (18/22) vs 73.1% (19/26),
representing a decline of 8.7%; Z-statistic = 0.727 p >
0.05. The mean age at presentation in relation to gender
was for boys 11.4 ± 3.9 years, 95% CI = 9.4-13.4 and for
girls 13.2 ± 1.8 years, 95% CI = 12.4-14.0; t = 1.671 p >
0.05. When both sexes were combined, the mean age at
presentation was 12.7 ± 2.6 years, 95% CI = 11.9-13.5.
The age and gender distribution of patients with DKA
are displayed in Table 1.
During the period under review, seven (19.8%; 5 girls
and 2 boys) of the 37 patients who were earlier regis-
tered and treated for DKA were hospitalized for the
second time in ketoacidosis, giving a female-to-male re-
admission ratio of 2.5:1. Omission of insulin was the
precipitating factor of DKA in 4 (57.1%) of the 7 patients
who were previously diagnosed and were being followed
up for T1DM. These four cases who omitted insulin
were because of proclaimed cure at spiritual healing
homes. Other clinical characteristics of the patients are
depicted in Table 2. The serum electrolyte profile at the
point of admission revealed that 27(73.0%) out of the 37
cases had moderate DKA. The remaining 10(27.0%) had
severe DKA. Over half (52.3%)of the families of the pa-
tients with DKA at initial presentation were of the mid-
dle social class while 11.2% were of the high social class
and 36.5% were of the low social class. Out of 37 cases
of newly-diagnosed T1DM manifesting with DKA, 69.4%
had symptoms for 2–3 weeks before presentation and
29.2% had had at least one medical consultation during
the period in a private clinic. Two (8.3%) had more than
one medical consultations during the same period. The
distribution of duration of symptoms before presentation
was as follows: less than 2 weeks 10.9%; 2–4 weeks
46.4%; 5–7 weeks 27.3%; and above 7 weeks in 15.4%.
The frequency of the presenting symptoms and signs is
displayed in Figure 1. Eight (21.6%) of the mothers
whose children presented with DKA admitted they did
not know that diabetes mellitus can occur in children.
The frequency of a positive family history of diabetes
mellitus was 8.1% and this involved two mothers and a
maternal grandmothers.
Table 2 Clinical characteristics of patients presenting
with DKA at initial diagnosis of T1DM
Clinical characteristics Mean values 95% CI
Mean duration of symptoms 2.3 ± 1.2 weeks 1.9-2.7
Mean blood glucose at point of
hospitalization
27.8 ± 10.6 mmol/L 24.4-31.2
Mean serum potassium 3.1 ± 1.6 mmol/L 2.6-3.6
Mean duration of fluid therapy 48.7 ± 10.3 hours 45.4-52.0
Mean time of switching from insulin
infusion to SC insulin
51.6 ± 12.4 hours 47.6-55.6
Discharge against medical advice 1 (2.7%)
Outcome of DKA (death or survival) No death
SC = Subcutaneous; CI = Confidence interval.
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bertal maturation; Tanner Stage II at the ages of 15 and
16 years respectively. None of the two has attained me-
narche at the ages of 16 and 17 years respectively. Their
weights and body mass indices were 29 Kg and 30 Kg;
16.0 Kg/m2 and 17.4 Kg/m2 respectively (both BMI
below the 5th percentile). One of the two girls had vagi-
nal candidiasis.
In all the patients, therapy was started with normal sa-
line and a continuous infusion of regular insulin at a rate
of 0.1 Units/kg/hour. Capillary blood glucose and serum
electrolytes were monitored 2 hourly and 12 hourly re-
spectively. As shown in Table 3, hypoglycaemia was the
most frequent complication encountered during the
management of DKA. No death was recorded.
Discussion
Slightly over three-quarter of the children and adoles-
cents in the present study manifested with DKA at first
diagnosis of diabetes. This is not surprising as a similar
high prevalence rate has been reported in a previous













Figure 1 Frequency of signs and symptoms among 37 patients with dIran and the United Arab Emirates [16,17]. However,
some studies [18,19] have reported lower prevalence
rates, all reflecting the well known wide geographic vari-
ation in frequency of DKA at onset of paediatric diabetes
mellitus [2,4]. The differing prevalence rates might be
explained by differences in study population, the back-
ground prevalence of diabetes in the given population,
presence or absence of family history of T1DM, family
socioeconomic status, delayed diagnosis and treatment
as well as the definition of DKA used in the particular
study. All these factors have been reported to influence
the prevalence of DKA at onset of type 1 diabetes
[18-20]. The relatively higher mean age (12.7 years) of
our patients may contribute to the observed higher
prevalence. This view is supported by a report from
Finland which indicated a higher prevalence among pa-
tients aged 10–14 years compared to those aged 5–
9 years [21]. Secular changes in frequency of DKA at on-
set of T1DM has equally been reported [21]. The clinical
implication of DKA as first presentation T1DM may be
viewed from two perspectives as proposed by Neu et al.
[8]. First, as a reflection of a delayed diagnosis and treat-
ment or as an aggressive form of diabetes. Either way, it
represents a poor prognostic factor. For instance, DKA
in newly diagnosed diabetes has been linked to a poorer
glycaemic control, [20,22] less residual β-cell function
(up to two years) after diagnosis, [23,24] and lower fre-
quency of remission [25,26].
Data from the present study indicate that over the
years, the frequency of DKA at diagnosis of new-onset
T1DM has not shown any significant decline when the
frequency during the initial 8 years (1996–2003) of the
16-year review was compared with the frequency in the
later 8 years (2004–2011). This finding is consistent with
report of Bui et al. [27]. In contrast, a study in Northern
Finland reported a significant decline in frequency (18.9
versus 29.5%) of DKA at first presentation of TIDM over60% 80% 100% 120%
iabetic ketoacidosis.
Table 3 Frequency of complications encountered in
patients admitted for DKA
Complications Number Percent
Hypoglycaemia (blood glucose < 3.3 mmol/L) 6 16.2
Hyponatraemia (serum sodium < 135 mmol/L) 3 8.1
Hypokalaemia (serum potassium < 3 mmol/L) 2 5.4
Hypocalcaemia (serum calcium < 2.2 mmol/L) 1 2.7
Hyperkalaemia (serum potassium > 5.5 mmol/L) 1 2.7
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ation is that the high background prevalence of diabetes
mellitus in Finland makes the recognition of the disease
easier by both the public and the physician. Increased
level of awareness of early symptoms of diabetes among
the populace and greater medical alertness to the occur-
rence of TIDM among the physicians will be rewarding.
This view is supported by two different findings in the
present study. First, nearly one-third of the patients who
had symptoms for 2–3 weeks before presentation in
DKA had at least one medical consultation during that
period in a private clinic, suggesting missed diagnosis
and, therefore, a window for intervention. Secondly, over
one-fifth of the mothers whose children presented in
DKA thought that diabetes mellitus was a disease exclu-
sive to the adult population, suggesting the need to in-
crease general public awareness of the symptoms of
diabetes mellitus.
Consistent with previous reports, [17,18] there was a
female preponderance among DKA patients in the
present study. This finding may be explained by the hor-
monal changes which accompany puberty, particularly
the elevation in the serum levels of some counter-
regulatory hormones, such as growth hormone and
oestrogen. These hormonal changes differ between boys
and girls. For instance, the level of oestrogen is by far
higher in girls than boys at puberty. In addition, cyto-
kines such as interleukin 1 (IL 1), interleukin 6 (IL 6)
and tumour necrosis factor (TNF) -alpha produced dur-
ing stress antagonize the effects of insulin promoting the
occurrence of DKA [28]. It is possible that cytokine-
response pattern to stress may differ between boys and
girls, precipitating DKA in girls with elevated counter-
regulatory. As noted earlier, the basic pathogenesis of
DKA is a decrease in the effective circulating insulin
associated with an elevation in the serum counter-
regulatory hormones [1,2].
The mean age at presentation in the present study was
significantly higher than that reported from some coun-
tries: Iran; [17] Saudi Arabia; [18] and Spain, [29] sug-
gesting that childhood T1DM presents at a relatively
older age in Nigeria. The youngest child in our series
was 5 years old. The reason for this difference is not
clear. It might be related to racial variations.In the present study, over one-quarter had severe form
of DKA. This is in agreement with the frequency of
severe DKA reported from Kuwait [19]. On the other
hand, the frequency of severe DKA observed in the
present study is four-to-five fold higher than that re-
ported from Finland [28]. The reason for this difference
might be that the background higher prevalence of
diabetes mellitus in Finland makes the recognition of the
disease easier by both the public and the physician,
reducing delays in diagnosis and treatment, ultimately
preventing severe form of DKA. The older age of our
patients might be contributory, given that the frequency
of severe form of DKA has been shown to be higher in
patients between the age 10–14 years compared to
patients aged 5–9 years [21]. Consistent with the report
of Habib, [18] majority of the patients with impaired
consciousness at presentation in the present study, had
severe form of DKA. In that study it was revealed that
there was a strong correlation between degree of acidosis
and depression of the central nervous system [18].
When compared with reports from developed coun-
tries of the west, [2,4,30,31] data from the present study
revealed some differences in clinical characteristics of
the patients. For instance, the prevalence of DKA at first
presentation of T1DM, the mean age at presentation,
the mean duration of symptoms before presentation and
the mean blood glucose at the point of admission were
all higher in the present series, representing some note-
worthy features of diabetes in children and adolescents
in a developing country. Similarly, reports from the Gulf
countries such as Saudi Arabia, Kuwait, United Arab
Emirates and Iran are generally in agreement with the
findings in the present study [16-18,26,32]. The impli-
cation is that the clinicians should be alert to these
differences depending on where they are practicing.
Hypoglycaemia was the leading complication encoun-
tered during the management of DKA in this series. It
occurred in one-sixth of the cases, indicating the need
for clinicians to be alert to its occurrence with the aim
of preventing it.
One limitation of the present study need to be consid-
ered. The relatively small sample size from one health-
care facility. Future multicentre study with a larger
sample size is being designed to enhance the interpret-
ation of results, and ultimately strengthen conclusions.
Despite this limitation, the study gave an insight into the
clinical characteristics of newly-diagnosed diabetes pre-
senting with DKA in our local community.
Conclusions
In conclusion, three-quarter of children and adolescents
present with DKA as first manifestation of T1DM with
no significant decline in frequency over a 16-year period
in UBTH.
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